Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats

Recent reports have indicated the potential usefulness of anticocaine catal ytic monoclonal antibodies in reducing cocaine's toxic and reinforcing effe cts by altering its pharmacokinetics to favor increased metabolism to the s ystemically inert products ecgonine methylester and benzoic acid. The prese nt study was designed to further these findings by evaluating the hypothesi s that administration of the anticocaine catalytic monoclonal antibody mAb 15A10 would dose and time dependently reduce behavior maintained by a range of doses of i.v. cocaine. Male Sprague-Dawley rats were trained in daily 8 -h sessions to self-administer i.v. cocaine. A within-session multiple-dose protocol was used wherein rats were allowed access to saline or one of six doses of cocaine [0 (saline), 0.015, 0.03, 0.06, 0 (saline), 0.125, 0.25, or 0.5 mg/kg/injection] each hour in the order stated. After demonstrating stable dose-response curves over 3 consecutive days, rats were given 30-min pretreatments of saline or mAb 15A10, (10, 30, or 100 mg/kg i.v.). Antibod y, but not saline, pretreatments significantly altered dose-response curves for cocaine self-administration in a dose- and time-dependent manner, resu lting in downward and rightward shifts in rates of responding across the co caine dose range. These effects were apparently not attributable to general behavioral suppression, because operant behavior for an alternative reinfo rcer was not likewise affected. The present data extend previous work indic ating that pharmacokinetic approaches may be of worth in the search for cli nically effective cocaine antagonists.